Get access

First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension

  • Protocol
  • Intervention

Authors

  • Wenlu Tang,

    Corresponding author
    1. University of British Columbia, Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver, BC, Canada
    • Wenlu Tang, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Vancouver, BC, V6T 1Z3, Canada. tangwenlu@gmail.com.

    Search for more papers by this author
  • Gavin WK Wong,

    1. University of British Columbia, Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver, BC, Canada
    Search for more papers by this author
  • Marco I Perez,

    1. University of British Columbia, Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver, BC, Canada
    Search for more papers by this author
  • James M Wright

    1. University of British Columbia, Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver, BC, Canada
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the benefits and harms of drugs inhibiting the RAS in patients with elevated blood pressure (>130/85mmHg).

Get access to the full text of this article